Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Rakesh Kumar, Jagdish"'
Autor:
Pushpa Yadav, Nirupama Trehanpati, Rakhi Maiwall, Rashi Sehgal, Ravinder Singh, Mojahidul Islam, Rakesh Kumar Jagdish, Rajan Vijayaraghavan, Deepanshu Maheshwari, Sadam Bhat, Pratibha Kale, Anupam Kumar, Sukriti Baweja, Guresh Kumar, Gayatri Ramakrishna, Shiv K. Sarin
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 2105-2120 (2022)
Abstract Patients with acute‐on‐chronic liver failure (ACLF) have a high probability of developing systemic inflammation and sepsis due to immune dysregulation. Fifty‐nine patients with ACLF (12 without and 19 with systemic inflammation, and 28
Externí odkaz:
https://doaj.org/article/b9585e788033439bab48f03bbbadcb7c
Autor:
Rakesh Kumar Jagdish, Akash Roy, Karan Kumar, Madhumita Premkumar, Mithun Sharma, Padaki Nagaraja Rao, Duvvur Nageshwar Reddy, Anand V. Kulkarni
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Cirrhosis transcends various progressive stages from compensation to decompensation driven by the severity of portal hypertension. The downstream effect of increasing portal hypertension severity leads to various pathophysiological pathways, which re
Externí odkaz:
https://doaj.org/article/d2bf6bb845c049a28bf3e282aa346c3c
Autor:
Deepanshu Maheshwari, Dhananjay Kumar, Rakesh Kumar Jagdish, Nidhi Nautiyal, Ashinikumar Hidam, Rekha Kumari, Rashi Sehgal, Nirupama Trehanpati, Sukriti Baweja, Guresh Kumar, Swati Sinha, Meenu Bajpai, Viniyendra Pamecha, Chhagan Bihari, Rakhi Maiwall, Shiv Kumar Sarin, Anupam Kumar
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveThe monocyte–macrophage system is central to the host’s innate immune defense and in resolving injury. It is reported to be dysfunctional in acute-on-chronic liver failure (ACLF). The disease-associated alterations in ACLF monocytes are
Externí odkaz:
https://doaj.org/article/edf93f42d18c4e23a4a103806e067e58
Autor:
Ankur Jindal, Rakesh Kumar Jagdish
Publikováno v:
Clinical and Molecular Hepatology, Vol 25, Iss 3, Pp 270-279 (2019)
Sarcopenia (loss of muscle mass and/or strength) frequently complicates liver cirrhosis and adversely affects the quality of life; cirrhosis related liver decompensation and significantly decreases wait-list and post-liver transplantation survival. T
Externí odkaz:
https://doaj.org/article/40749e6bee8843a09bffa73ad1647133
Autor:
Rakesh Kumar Jagdish
Publikováno v:
Annals of Geriatric Education and Medical Sciences. 9:6-9
Management of masks disposal in the COVID-19 era is a highly ignored segment in public health management and clinical care, which might be due to the unexpected emergence of pandemic and unpreparedness of the system. Meanwhile with over time newer in
Autor:
Amar Mukund, Shakti Prasad Choudhury, Tara Prasad Tripathy, Venkatesh Hosur Ananthashayana, Rakesh Kumar Jagdish, Vinod Arora, Satender Pal Singh, Ajay Kumar Mishra, Shiv Kumar Sarin
Publikováno v:
Hepatology International. 16:1496-1498
Autor:
Sushrut Singh, Rakesh Kumar Jagdish, Ankur Kumar Jindal, Sanchit Sharma, Samagra Agarwal, Anoop Saraya, Shiv Kumar Sarin, Deepak Gunjan
Publikováno v:
J Clin Exp Hepatol
BACKGROUND AND AIMS: Noninvasive tools (NITs) reliably categorise patients with compensated advanced chronic liver disease (cACLD) into high-risk and low-risk group for harbouring varices needing treatment. Here, we assess the ability of these NITs t
Publikováno v:
J Clin Exp Hepatol
End-stage liver disease is characterized by massive hepatocyte death resulting in clinical decompensation and organ failures. Clinical consequences in cirrhosis are the results of the loss of functional hepatocytes and excessive scarring. The only cu
Autor:
Rakesh Kumar Jagdish
Publikováno v:
Annals of Geriatric Education and Medical Sciences. 9:37-39
Sleromyxedema is a rare disease characterised by extensive mucin deposition with fibrosis in dermis. It is often associated with monoclonal gammopathy. Its true prevalence and/or cause is unknown due to its rarity. Various extra-cutaneous manifestati
Autor:
Ankur Kumar Jindal, Rakesh Kumar Jagdish, Saggere Muralikrishna Shasthry, V Rajan, Vinod Arora, Ashok Choudhary, Jaya Benjamin, Manoj Kumar, Ahmed Kamaal, Guresh Kumar, Ankit Bhardwaj, Rakhi Maiwall, Shiv Kumar Sarin
Publikováno v:
Hepatology International. 17:434-451
Patients with cirrhosis have high prevalence of erectile dysfunction (ED). The aim of this study was to study the efficacy and safety of tadalafil for ED in patients with cirrhosis.140 cirrhotic males with ED were randomized into tadalafil 10 mg dail